Pharmacology of antidepressants

被引:145
作者
Richelson, E
机构
[1] Mayo Clin, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA
[2] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
关键词
D O I
10.4065/76.5.511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Presently in the United States, 21 compounds have been approved by the Food and Drug Administration as antidepressants, Two additional drugs marketed outside the United States as antidepressants have been approved for obsessive-compulsive disorder. Nearly one half of all these compounds became available within the past 12 years, whereas the first antidepressant was available more than 40 years ago. After the clinical aspects of depression are introduced in this article, the pharmacology of the newer generation drugs is reviewed in relationship to the older compounds, The information in this review will help clinicians treat acute depression with pharmacological agents.
引用
收藏
页码:511 / 527
页数:17
相关论文
共 174 条
[11]   FUNCTIONAL INTERRELATIONSHIP OF SEROTONIN AND NOREPINEPHRINE - CORTISOL RESPONSES TO MCPP AND DMI IN PATIENTS WITH PANIC DISORDER, PATIENTS WITH DEPRESSION, AND NORMAL CONTROL SUBJECTS [J].
ASNIS, GM ;
WETZLER, S ;
SANDERSON, WC ;
KAHN, RS ;
VANPRAAG, HM .
PSYCHIATRY RESEARCH, 1992, 43 (01) :65-76
[12]   The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine [J].
Attar-Lévy, D ;
Martinot, JL ;
Blin, J ;
Dao-Castellana, MH ;
Crouzel, C ;
Mazoyer, B ;
Poirier, MF ;
Bourdel, MC ;
Aymard, N ;
Syrota, A ;
Féline, A .
BIOLOGICAL PSYCHIATRY, 1999, 45 (02) :180-186
[13]   Possible induction of mania and hypomania by olanzapine or risperidone: A critical review of reported cases [J].
Aubry, JM ;
Simon, AE ;
Bertschy, G .
JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (09) :649-655
[14]   No effect of the new antidepressant reboxetine on CYP2D6 activity in healthy volunteers [J].
Avenoso, A ;
Facciolà, G ;
Scordo, MG ;
Spina, E .
THERAPEUTIC DRUG MONITORING, 1999, 21 (05) :577-579
[15]   INTERACTIONS OF FLUOXETINE WITH METABOLISM OF DOPAMINE AND SEROTONIN IN RAT-BRAIN REGIONS [J].
BALDESSARINI, RJ ;
MARSH, ER ;
KULA, NS .
BRAIN RESEARCH, 1992, 579 (01) :152-156
[16]   Venlafaxine: In vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; Comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYPIA2 [J].
Ball, SE ;
Ahern, D ;
Scatina, J ;
Kao, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) :619-626
[17]   The prevalence, associations and symptoms of depression amongst dementia sufferers [J].
Ballard, C ;
Bannister, C ;
Solis, M ;
Oyebode, F ;
Wilcock, G .
JOURNAL OF AFFECTIVE DISORDERS, 1996, 36 (3-4) :135-144
[18]   NORADRENERGIC INNERVATION OF SEROTONERGIC NEURONS IN THE DORSAL RAPHE - DEMONSTRATION BY ELECTRON-MICROSCOPIC AUTORADIOGRAPHY [J].
BARABAN, JM ;
AGHAJANIAN, GK .
BRAIN RESEARCH, 1981, 204 (01) :1-11
[19]   COADMINISTRATION OF NEFAZODONE AND BENZODIAZEPINES .2. A PHARMACOKINETIC INTERACTION STUDY WITH TRIAZOLAM [J].
BARBHAIYA, RH ;
SHUKLA, UA ;
KROBOTH, PD ;
GREENE, DS .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (05) :320-326
[20]   5-HT2 RECEPTOR SUBTYPES - A FAMILY RE-UNITED [J].
BAXTER, G ;
KENNETT, G ;
BLANEY, F ;
BLACKBURN, T .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (03) :105-110